INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,589 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
MD
Metzfield DennisVP, PAO & Controller
BAHBooz Allen Hamilton Holding Corp
Tax withholding
F$20K
229 sh
Jan 30, 2026Feb 4, 2026
Page 1327 of 1765
← PrevNext →
traded Jan 30, 2026
+5d
SEC Form 4

Evidence

19
FN
France NatashaSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
10.4K sh
Feb 1, 2026Feb 4, 2026
traded Feb 1, 2026
+3dSEC Form 4

Evidence

19
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$187K
4,064 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$186K
1,233 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

19
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

19
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$378K
1,639 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

19
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$106K
720 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
JM
Jones Jeanne MEVP, CFO, Audit & Risk
EXCEXELON CORP
Disposition to issuer
D$314K
7,154 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

18
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$3.80M
52.6K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
GC
Gutman CarrieSenior Vice President
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
763 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Grant or award
A—
483.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
RC
Raub ChristopherExecutive Vice President
JXNJackson Financial Inc.
Grant or award
A—
11.2K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
MC
Malabre Richard CSVP, Chief Accounting Officer
AKBAAkebia Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
36.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
JM
Jones Jeanne MEVP, CFO, Audit & Risk
EXCEXELON CORP
Option exercise
M—
24.7K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
14.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
HK
Hill Donna K.VP, Human Resources
TLSTELOS CORP
Grant or award
A—
17.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
146.5K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$18
1 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

17
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
25.9K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
20.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
RD
Robinson-Gay DonaldSenior Vice President
LKFNLAKELAND FINANCIAL CORP
Tax withholding
F$57K
939 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
878 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$140K
600 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Tax withholding
F$79K
3,859 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
KA
Kleczynski Robert ASVP, Controller & Tax
EXCEXELON CORP
Tax withholding
F$165K
3,768 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
KA
Kleczynski Robert ASVP, Controller & Tax
EXCEXELON CORP
Disposition to issuer
D$218K
4,963 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
FD
Frost DianaDirector
WWayfair Inc.
Tax withholding
F$57K
548 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
CE
Clark Kyra ESenior Vice President
LKFNLAKELAND FINANCIAL CORP
Tax withholding
F$63K
1,045 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
850 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$133K
576 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

15
FJ
Frew JamesSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
50.6K sh
Feb 1, 2026Feb 4, 2026
traded Feb 1, 2026
+3dSEC Form 4

Evidence

15
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Small acquisition
L$6,350
588 sh
Jan 27, 2026Feb 4, 2026
traded Jan 27, 2026
+8dSEC Form 4

Evidence

15
FN
France NatashaSEE REMARKS
AMPYAmplify Energy Corp.
Tax withholding
F$16K
3,100 sh
Feb 1, 2026Feb 4, 2026
traded Feb 1, 2026
+3dSEC Form 4

Evidence

15
FD
Furbee DanielDirector, SEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
51.6K sh
Feb 1, 2026Feb 4, 2026
traded Feb 1, 2026
+3dSEC Form 4

Evidence

15
JD
Jahnel DarrinDirector
AROWARROW FINANCIAL CORP
Grant or award
A$2,238
69 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

15
DM
Dawsey James MDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

15
WJ
White Daniel JamesDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

15
MJ
Munari Alvise J.Chief Product Officer
MSCIMSCI Inc.
Tax withholding
F$274K
438 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

13
KA
Kleczynski Robert ASVP, Controller & Tax
EXCEXELON CORP
Option exercise
M—
7,019 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence